While the Affordable Care Act, Pope Francis, and the government shutdown were top general news stories in 2013, the bio/pharmaceutical industry had its own headlines.
While the Affordable Care Act, Pope Francis, and the government shutdown were top general news stories in 2013, the bio/pharmaceutical industry had its own headlines. Pharmaceutical Technology analyzed the hundreds of news stories published in 2013, and found the top 10 most-read articles, based on reader clicks. To no surprise, the most-read articles reflect major bio/pharmaceutical business announcements and regulatory activity.
Merck Cuts 8,500 Positions, Moves Headquarters
Scientist Jailed for Falsifying Research Data
FDA Lists Guidance Documents Planned for 2013
Ben Venue Laboratories Enters Consent Decree
AstraZeneca Announces an Additional 2300 Layoffs
Hameln Pharmaceuticals Receives FDA Warning Letter
Novartis Receives FDA Warning Letter for cGMP Violations at Austrian Plant
Pfizer Voluntarily Recalls Levoxyl
AstraZeneca to Cut 1600 Positions in R&D Reorganization
To stay on top of pharmaceutical industry news in 2014, subscribe to a Pharmaceutical Technology newsletter.
ePharmTechnology (ePT) | Weekly
The latest in business, scientific and regulatory news shorts, plus upcoming events and webcasts delivered to your inbox every Thursday. Subscribe
Pharmaceutical Technology Europe e-Alert | Weekly
The latest in business, scientific and regulatory news shorts, with a special focus on the European marketplace, delivered to your inbox every Tuesday. Subscribe
Sourcing & Management | Monthly
Analysis of pharmaceutical development, manufacturing, and the supply chain. Subscribe
Equipment and Processing Report | Monthly
Focus on pharmaceutical manufacturing processes and technology, providing analysis of manufacturing news, related regulatory issues, and current trends. Subscribe
PharmTech Whitepaper Alert | Monthly Receive free technical whitepapers and application notes submitted by leading pharmaceutical manufacturing product and solution providers. Subscribe